The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions
- PMID: 35327559
- PMCID: PMC8945214
- DOI: 10.3390/biom12030367
The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions
Abstract
Cancer is a complex disease resulting from the genetic and epigenetic disruption of normal cells. The mechanistic understanding of the pathways involved in tumor transformation has implicated a priori predominance of epigenetic perturbations and a posteriori genetic instability. In this work, we aimed to explain the mechanistic involvement of epigenetic pathways in the cancer process, as well as the abilities of natural bioactive compounds isolated from medicinal plants (flavonoids, phenolic acids, stilbenes, and ketones) to specifically target the epigenome of tumor cells. The molecular events leading to transformation, angiogenesis, and dissemination are often complex, stochastic, and take turns. On the other hand, the decisive advances in genomics, epigenomics, transcriptomics, and proteomics have allowed, in recent years, for the mechanistic decryption of the molecular pathways of the cancerization process. This could explain the possibility of specifically targeting this or that mechanism leading to cancerization. With the plasticity and flexibility of epigenetic modifications, some studies have started the pharmacological screening of natural substances against different epigenetic pathways (DNA methylation, histone acetylation, histone methylation, and chromatin remodeling) to restore the cellular memory lost during tumor transformation. These substances can inhibit DNMTs, modify chromatin remodeling, and adjust histone modifications in favor of pre-established cell identity by the differentiation program. Epidrugs are molecules that target the epigenome program and can therefore restore cell memory in cancerous diseases. Natural products isolated from medicinal plants such as flavonoids and phenolic acids have shown their ability to exhibit several actions on epigenetic modifiers, such as the inhibition of DNMT, HMT, and HAT. The mechanisms of these substances are specific and pleiotropic and can sometimes be stochastic, and their use as anticancer epidrugs is currently a remarkable avenue in the fight against human cancers.
Keywords: DNMT; HDAC; cancer; cancer therapy; epidrugs; pharmacodynamic.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8945214/bin/biomolecules-12-00367-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8945214/bin/biomolecules-12-00367-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8945214/bin/biomolecules-12-00367-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8945214/bin/biomolecules-12-00367-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8945214/bin/biomolecules-12-00367-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8945214/bin/biomolecules-12-00367-g006.gif)
Similar articles
-
Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates.Molecules. 2022 Apr 15;27(8):2568. doi: 10.3390/molecules27082568. Molecules. 2022. PMID: 35458763 Free PMC article. Review.
-
Anticancer mechanisms of phytochemical compounds: focusing on epigenetic targets.Environ Sci Pollut Res Int. 2021 Sep;28(35):47869-47903. doi: 10.1007/s11356-021-15594-8. Epub 2021 Jul 26. Environ Sci Pollut Res Int. 2021. PMID: 34308524 Review.
-
Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy.Curr Pharm Des. 2019;25(6):635-641. doi: 10.2174/1381612825666190405144026. Curr Pharm Des. 2019. PMID: 30950345 Review.
-
Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation.Curr Pharm Des. 2017;23(8):1167-1174. doi: 10.2174/1381612822666161021110827. Curr Pharm Des. 2017. PMID: 27774908 Review.
-
The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.Gene. 2015 May 10;562(1):8-15. doi: 10.1016/j.gene.2015.02.045. Epub 2015 Feb 19. Gene. 2015. PMID: 25701602 Review.
Cited by
-
The pharmacoepigenetic paradigm in cancer treatment.Front Pharmacol. 2024 Apr 24;15:1381168. doi: 10.3389/fphar.2024.1381168. eCollection 2024. Front Pharmacol. 2024. PMID: 38720770 Free PMC article. Review.
-
The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review.Curr Oncol. 2024 Apr 3;31(4):1994-2023. doi: 10.3390/curroncol31040149. Curr Oncol. 2024. PMID: 38668052 Free PMC article. Review.
-
Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs.Sci Rep. 2024 Apr 25;14(1):9540. doi: 10.1038/s41598-024-60395-x. Sci Rep. 2024. PMID: 38664447 Free PMC article.
-
Epigenetic modifiers as inducer of bioactive secondary metabolites in fungi.Biotechnol Lett. 2024 Jun;46(3):297-314. doi: 10.1007/s10529-024-03478-z. Epub 2024 Apr 12. Biotechnol Lett. 2024. PMID: 38607602 Review.
-
Epigenetic regulation of mRNA mediates the phenotypic plasticity of cancer cells during metastasis and therapeutic resistance (Review).Oncol Rep. 2024 Feb;51(2):28. doi: 10.3892/or.2023.8687. Epub 2023 Dec 22. Oncol Rep. 2024. PMID: 38131215 Free PMC article. Review.
References
-
- Ruddon R.W. Cancer Biology. Oxford University Press; Oxford, UK: 2007.
-
- G C O Global Cancer Observatory. [(accessed on 16 September 2021)]. Available online: https://gco.iarc.fr/
-
- Hanahan D., Weinberg R.A. Biological Hallmarks of Cancer. In: Bast R.C., Croce C.M., Hait W., Hong W.K., Kufe D.W., Pollock R.E., Weichselbaum R.R., Holland J.F., editors. Holland-Frei Cancer Medicine. John Wiley & Sons; Hoboken, NJ, USA: 2017. pp. 9–16.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources